4-121879801-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001130698.2(TRPC3):c.2701G>A(p.Glu901Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000342 in 1,608,146 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001130698.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152062Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000246 AC: 6AN: 244046Hom.: 0 AF XY: 0.00000758 AC XY: 1AN XY: 131906
GnomAD4 exome AF: 0.0000350 AC: 51AN: 1456084Hom.: 0 Cov.: 30 AF XY: 0.0000318 AC XY: 23AN XY: 724080
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152062Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74294
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.2701G>A (p.E901K) alteration is located in exon 12 (coding exon 12) of the TRPC3 gene. This alteration results from a G to A substitution at nucleotide position 2701, causing the glutamic acid (E) at amino acid position 901 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 901 of the TRPC3 protein (p.Glu901Lys). This variant is present in population databases (rs200028855, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with TRPC3-related conditions. ClinVar contains an entry for this variant (Variation ID: 2462609). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TRPC3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at